圣达生物: 浙江圣达生物药业股份有限公司关于使用闲置募集资金进行现金管理到期赎回的公告

Group 1 - The company approved the use of idle raised funds for cash management, with a limit of RMB 230 million, to purchase safe and liquid financial products with a maturity of no more than 12 months [2] - The company has already invested RMB 80 million in structured deposits with China Construction Bank, Zhejiang Branch [2] - The investment yielded a return of RMB 119,300, which aligns with the expected returns [3] Group 2 - The cash management products include structured deposits and large certificates of deposit, ensuring capital preservation [2] - The funds can be rolled over within the specified limit and timeframe, with the chairman authorized to finalize agreements [2] - The principal and returns from the financial products have been returned to the raised funds account [3]